EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:33276 - δ-tocotrienol
| Formula | C27H40O2 |
| Net Charge | 0 |
| Average Mass | 396.615 |
| Monoisotopic Mass | 396.30283 |
| SMILES | CC(C)=CCC/C(C)=C/CC/C(C)=C/CC[C@]1(C)CCc2cc(O)cc(C)c2O1 |
| InChI | InChI=1S/C27H40O2/c1-20(2)10-7-11-21(3)12-8-13-22(4)14-9-16-27(6)17-15-24-19-25(28)18-23(5)26(24)29-27/h10,12,14,18-19,28H,7-9,11,13,15-17H2,1-6H3/b21-12+,22-14+/t27-/m1/s1 |
| InChIKey | ODADKLYLWWCHNB-LDYBVBFYSA-N |
| Species of Metabolite | Component | Source | Comments |
|---|---|---|---|
| Saccharomyces cerevisiae (ncbitaxon:4932) | - | PubMed (32580548) |
| Roles Classification |
|---|
| Chemical Roles: | antioxidant A substance that opposes oxidation or inhibits reactions brought about by dioxygen or peroxides. antioxidant A substance that opposes oxidation or inhibits reactions brought about by dioxygen or peroxides. antioxidant A substance that opposes oxidation or inhibits reactions brought about by dioxygen or peroxides. |
| Biological Roles: | apoptosis inducer Any substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms. NF-kappaB inhibitor An inhibitor of NF-κB (nuclear factor κ-light-chain-enhancer of activated B cells), a protein complex involved in the transcription of DNA. Saccharomyces cerevisiae metabolite Any fungal metabolite produced during a metabolic reaction in Baker's yeast (Saccharomyces cerevisiae ). plant metabolite Any eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. fat-soluble vitamin (role) Any vitamin that dissolves in fats and are stored in body tissues. Unlike the water-soluble vitamins, they are stored in the body for long periods of time and generally pose a greater risk for toxicity when consumed in excess. |
| Applications: | bone density conservation agent An agent that inhibits bone resorption and/or favor bone mineralization and bone regeneration. Used to heal bone fractures and to treat bone diseases such as osteopenia and osteoporosis. radiation protective agent Any compound that is able to protect normal cells from the damage caused by radiation therapy. anti-inflammatory agent Any compound that has anti-inflammatory effects. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. cardiovascular drug A drug that affects the rate or intensity of cardiac contraction, blood vessel diameter or blood volume. antiparkinson drug A drug used in the treatment of Parkinson's disease. antiatherosclerotic agent A cardiovascular drug that prevents atherosclerosis (a disease in which the inside of an artery narrows due to the build up of plaque). Compare with antiatherogenic agent. antipsychotic agent Antipsychotic drugs are agents that control agitated psychotic behaviour, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. hypoglycemic agent A drug which lowers the blood glucose level. anti-inflammatory agent Any compound that has anti-inflammatory effects. vulnerary A drug used in treating and healing of wounds. antidote Any protective agent counteracting or neutralizing the action of poisons. antifibrotic agent Any agent which acts to reduce fibrosis. renoprotective agent Any compound that is able to prevent damage to the kidneys. antiinfective agent A substance used in the prophylaxis or therapy of infectious diseases. anti-asthmatic agent Any compound that has anti-asthmatic effects. anti-anaemic agent A compound which increases either the number of red cells or the amount of haemoglobin in the blood. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. antipsoriatic A drug used to treat psoriasis. hepatoprotective agent Any compound that is able to prevent damage to the liver. ophthalmology drug Any compound used for the treatment of eye conditions or eye diseases. antiglaucoma drug Any drug which can be used to prevent or alleviate glaucoma, a disease in which the optic nerve is damaged, resulting in progressive, irreversible loss of vision. It is often, though not always, associated with increased pressure of the fluid in the eye. antirheumatic drug A drug used to treat rheumatoid arthritis. antidepressant Antidepressants are mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| δ-tocotrienol (CHEBI:33276) has role Saccharomyces cerevisiae metabolite (CHEBI:75772) |
| δ-tocotrienol (CHEBI:33276) has role anti-inflammatory agent (CHEBI:67079) |
| δ-tocotrienol (CHEBI:33276) has role antineoplastic agent (CHEBI:35610) |
| δ-tocotrienol (CHEBI:33276) has role apoptosis inducer (CHEBI:68495) |
| δ-tocotrienol (CHEBI:33276) has role bone density conservation agent (CHEBI:50646) |
| δ-tocotrienol (CHEBI:33276) has role NF-κB inhibitor (CHEBI:73240) |
| δ-tocotrienol (CHEBI:33276) has role plant metabolite (CHEBI:76924) |
| δ-tocotrienol (CHEBI:33276) has role radiation protective agent (CHEBI:66987) |
| δ-tocotrienol (CHEBI:33276) is a tocotrienol (CHEBI:33235) |
| δ-tocotrienol (CHEBI:33276) is a vitamin E (CHEBI:33234) |
| IUPAC Name |
|---|
| (2R)-2,8-dimethyl-2-[(3E,7E)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl]-3,4-dihydro-2H-chromen-6-ol |
| Synonyms | Source |
|---|---|
| (2R)-2,8-dimethyl-2-[(3E,7E)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl]-3,4-dihydro-2H-1-benzopyran-6-ol | IUPAC |
| delta-tocotrienol | KEGG COMPOUND |
| δ-tocotrienol | ChemIDplus |
| UniProt Name | Source |
|---|---|
| δ-tocotrienol | UniProt |
| Manual Xrefs | Databases |
|---|---|
| 4445515 | ChemSpider |
| C00035077 | KNApSAcK |
| C14156 | KEGG COMPOUND |
| CPD-15839 | MetaCyc |
| FDB001299 | FooDB |
| HMDB0030008 | HMDB |
| LMPR02020056 | LIPID MAPS |
| WO2009126866 | Patent |
| Registry Numbers | Sources |
|---|---|
| Reaxys:5449575 | Reaxys |
| CAS:25612-59-3 | ChemIDplus |
| CAS:25612-59-3 | NIST Chemistry WebBook |
| Citations |
|---|